Document is current
Any future updates will be listed below
-
Authors
Elkind-Hirsch, Karen E.
Armatta, Missy
Veillon, Edward
Schiavon, Sara
Cappon, Giacomo
-
Funding
Funding for this research was provided by:
Dexcom (Reference # IIS-2021-120)
- License Information
-
More Information
Article History
Received: 18 July 2025
Accepted: 10 March 2026
First Online: 16 March 2026
Declarations
:
: All participants in the study provided informed written consent. The protocol was approved by the Woman’s Hospital Foundation Institutional Review Board of Woman’s Hospital where the study was carried out.
: Not applicable.
: Karen Elkind-Hirsch reports receiving grant support from Dexcom, Inc. and Novo Nordisk and has served on an advisory board for Lilly and NovoNordisk. She now is an employee for Dexcom, Inc., Missy Armatta, Edward Veillon, Sara Schiavon, and Giacomo Cappon have nothing to disclose. No other potential conflict of interest relevant to this article exists.
